Bone Cancer Drugs Market is Estimated To Witness High Growth Owing To Advancements in Targeted Therapy
The Bone Cancer Drugs Market is estimated to be valued at US$ 1,286.4 Mn in 2023 and is expected to exhibit a CAGR of 5.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Bone cancer drugs are used for the treatment of cancer that arises from bones. The most common types of bone cancer are osteosarcoma and Ewing's...
0 Comments
0 Shares